(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 7.06% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.01%.
Neuronetics's revenue in 2026 is $159,761,000.On average, 6 Wall Street analysts forecast STIM's revenue for 2026 to be $12,867,921,886, with the lowest STIM revenue forecast at $12,340,146,654, and the highest STIM revenue forecast at $13,262,781,706. On average, 6 Wall Street analysts forecast STIM's revenue for 2027 to be $14,029,182,852, with the lowest STIM revenue forecast at $13,384,037,871, and the highest STIM revenue forecast at $14,576,390,162.
In 2028, STIM is forecast to generate $15,248,740,052 in revenue, with the lowest revenue forecast at $14,465,238,677 and the highest revenue forecast at $16,037,682,409.